Inventor · disambiguated record
Matthias Magoola
Also filed as: MAGOOLA MATTHIAS
0 granted patents·22 pending applications·0 citations·filing 2023–2024
Top patents by PatentIndex Score
22 records- 0173US2025360198A1mRNA-based HIV Vaccine For Acute and Latent InfectionsMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0270US2025388658A1Single chain variable fragment transferrin fusion protein (rnat26) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0370US2025388660A1Single chain variable fragment transferrin fusion protein (rnat55) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0470US2025388657A1Single chain variable fragment transferrin fusion protein (rnat06) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0570US2025388659A1Single chain variable fragment transferrin fusion protein (rnat52) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0670US2025388661A1Single chain variable fragment transferrin fusion protein (rnat60) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0770US2025388656A1Single chain variable fragment transferrin fusion protein (rnat01) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0870US2025387502A1Single chain variable fragment transferrin fusion protein (rnat40) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 0970US2025381288A1Anti-VEGF Single Chain Variable Fusion Protein (RNAT92)NIAZI SARFARAZ K·Filed 2024·Application pending·0 cites
- 1070US2025382360A1Anti-VEGF Single Chain Variable Fusion Protein (RNAT82)MAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 1169US2025360197A1mRNA-based HIV Vaccine For Acute and Latent InfectionsMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 1269US2025381287A1Anti-VEGF Fusion Protein (RNAT53)NIAZI SARFARAZ K·Filed 2024·Application pending·0 cites
- 1369US2025387500A1Single chain variable fragment transferrin fusion protein (rnat15) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 1469US2025387501A1Single chain variable fragment transferrin fusion protein (rnat31) to treat neurodegenerative disordersMAGOOLA MATTHIAS·Filed 2024·Application pending·0 cites
- 1568US2024285742A1Universal mRNA Antimalarial VaccineNIAZI SARFARAZ K·Filed 2023·Application pending·0 cites
- 1668US2024299439A1TNF-alpha Protein Inhibiting mRNA VaccineNIAZI SARFARAZ K·Filed 2024·Application pending·0 cites
- 1768US2024277753A1mRNA-based In Vivo Encoding of Darbepoetin AlphaNIAZI SARFARAZ K·Filed 2024·Application pending·0 cites
- 1868US2024293519A1Universal mRNA Vaccine to Treat Dementia-Causing Neurodegenerative DisordersNIAZI SARFARAZ K·Filed 2024·Application pending·0 cites
- 1967US2025161389A1Herbal composition for the treatment of malariaMAGOOLA MATTHIAS·Filed 2023·Application pending·0 cites
- 2067US2024207303A1mNA-based Delivery of Botulinum ToxinNIAZI SARFARAZ K·Filed 2023·Application pending·0 cites
- 2167US2025043258A1CRISPR-based DNA Repair-Inhibiting Intratumoral Cancer TherapyNIAZI SARFARAZ K·Filed 2023·Application pending·0 cites
- 2267US2024269260A1mRNA-Based Vaccine Composition for Inducing Immune Response Against HIV and HPVNIAZI SARFARAZ K·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Magoola files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →